Genocea Biosciences Revenue, Profits - GNCA Annual Income Statement

Add to My Stocks
$0.51 $0.01 (2%) GNCA stock closing price Sep 19, 2018 (Closing)

Fundamental analysis of GNCA stock involves analyzing its financial statements, apart from checking the Genocea Biosciences stock price. An income statement is one of the three key financial statements furnished by a company, the other two being the balance sheet and the cashflow statement. Like any other income statement, the GNCA income statement also itemizes revenue/sales, operating expenses, and profits/bottomline for a quarter or year and reflects a YOY revenue decline of 0 when compared to the same period in the past. The operating expenses as shown in the Genocea Biosciences profit and loss statement for 2017 total to $55.25M. This line item shows that the operating expenses has increased compared with last year. Also check: Genocea Biosciences assets and Genocea Biosciences free cash flow.

View revenue and profit details for latest and last 10 financial years.
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec2017201620152014201320122011
Genocea Biosciences Revenues or Net Sales
-----1.97M1.82M
Cost Of Goods Sold (COGS)-------
Genocea Biosciences Gross Profit
-----1.97M1.82M
Research & Development Expense39.2M33.05M28.04M23.72M15.69M11.24M13.54M
Selling General & Admin Expense16.05M15.42M13.98M9.74M4.96M3.69M3M
Income Before Depreciation Depletion Amortization-55.25M-48.24M-41.36M-33.16M-19.92M-12.95M-14.72M
Depreciation Depletion Amortization-------
Non Operating Income----1.16M-0.42M--
Interest Expense1.7M1.73M1.11M----
Genocea Biosciences Pretax Income
-56.71M-49.57M-42.48M-35.29M-20.8M-13.36M-14.68M
Provision for Income Taxes-------
MinorityInterest-------
Investment Gains Losses-------
Other Income-------
Income Before Extraordinaries & Disc Operations-56.71M-49.57M-42.48M-35.29M-20.8M-13.36M-14.68M
Extraordinary Items & Discontinued Operations-------
Genocea Biosciences Profit/ Loss (Net Income)
-56.71M-49.57M-42.48M-35.29M-20.8M-13.36M-14.68M
Average Shares used to compute Diluted EPS28.6M28.3M24.46M15.62M---
Average Shares used to compute Basic EPS28.6M28.3M24.46M15.62M---
Income Before Nonrecurring Items-56.71M-49.57M-42.48M-35.3M-20.81M--
Income from Nonrecurring Items-------
Genocea Biosciences Earnings Per Share Basic Net
-1.98-1.75-1.74-2.27-75.46--
Genocea Biosciences Earnings Per Share Diluted Net
-1.98-1.75-1.74-2.27-75.46--
EPS Diluted Before Nonrecurring Items-1.98-1.75-1.74-2.27-75.46--
Preferred Dividends Acc Pd-------
Dividends Common-------
Dividend Per Share Common0.000.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

The key things to look for in an income statement while doing Genocea Biosciences stock analysis are:

  • Revenue: The money received by selling of goods or services comes under this line item. A YoY growth - See: Genocea Biosciences revenue chart implies that the company is growing. It has not been the case with Genocea Biosciences. One must look at stocks with increasing revenues, and stay away from stocks whose revenues or sales are declining.
  • Bottom line: This refers to the last line in a profit and loss statement and denotes the net profit or loss for a particular period. The figure currently stands at $-56.71M for Genocea Biosciences for 2017. This figure is arrived at after deducting all operating expenses, interest, and taxes from revenue.

The income statement is also called statement of revenue and expense. The GNCA financials along with Genocea Biosciences historical stock prices provide a lot of details about the firm.

Genocea Biosciences Income Statement - Key Financial Ratios

Operating Margin
0
Net Profit Margin
0